Sunflower Pharmaceutical executive vice president resigns
Sunflower Pharmaceutical Group Co., Ltd. announced that Executive Vice President Chen Liang submitted a written resignation to the board of directors, citing personal reasons. Chen Liang will no longer hold any position within the company or its subsidiaries following his departure. As of the announcement date, Chen Liang does not hold any shares in the company. The company confirms that Chen Liang's resignation will not significantly impact production or operations and expresses gratitude for his contributions during his tenure. The resignation is effective from the date the report was submitted to the board.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
News Alerts
Get instant email alerts when Sunflower Pharmaceutical Group publishes news
Free account required • Unsubscribe anytime